PF-05230907

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-05230907, covering 2016-04-22 to 2019-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage [Phase 1]